Evidence for the involvement of central serotonergic mechanisms in cholinergic tremor induced by tacrine in Balb/c mice

Behavioural Brain Research

Volumn 163, Issue 2, 2005, Pages 227-236

  Mehta, Hina ^a   Haobam, Reena ^a   Usha, Rajamma ^b   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Manovikas Biomedical Research and Diagnostic Centre   (India)

Author keywords

5 HT 2A 2C receptor; 5 HT synthesis inhibition; Acetylcholine synthesis; Catecholamines; Cholinergic receptor; Serotonin; Tremor

Indexed keywords

ATROPINE; BIOGENIC AMINE; CHOLINE ACETYLTRANSFERASE; DOPAMINE; FENCLONINE; METHYSERGIDE; MIANSERIN; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; SEROTONIN; SEROTONIN 2A ANTAGONIST; TACRINE; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROCHEMISTRY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEUS ACCUMBENS; OLIVARY NUCLEUS; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; STRIATE CORTEX; SUBSTANTIA NIGRA; TREMOR;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; ATROPINE; BEHAVIOR, ANIMAL; BIOGENIC AMINES; BRAIN; BRAIN CHEMISTRY; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MICE; MICE, INBRED BALB C; MUSCARINIC ANTAGONISTS; SEROTONIN; SEROTONIN ANTAGONISTS; TACRINE; TIME FACTORS; TREMOR;

EID: 23744488737     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.05.002     Document Type: Article

References (49)

1. A. Adem, S.S. Jossan, and L. Oreland Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase Neurosci Lett 107 1989 313 317
2. F.P. Bymaster, P.A. Carter, S.C. Peters, W. Zhang, J.S. Ward, and C.H. Mitch Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects Brain Res 795 1998 179 190
3. B.B. Carlson, A. Wisniecki, and J.D. Salamone Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of parkinsonian tremor Psychopharmacology 165 2003 229 237
4. L.P. Chao, and F. Wolfgram Spectrophotometric assay for choline acetyltransferase Anal Biochem 46 1972 114 118
5. M.S. Cousins, D.L. Carriero, and J.D. Salamone Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs Eur J Pharmacol 322 1997 137 145
6. M.S. Cousins, A. Atherton, and J.D. Salamone Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements Physiol Behav 64 1998 153 158
7. M.S. Cousins, M. Finn, J. Trevitt, D.L. Carriero, A. Conlan, and J.D. Salamone The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements Pharmacol Biochem Behav 62 1999 439 447
8. J.N. Crawley, J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel, and N. Henderson Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies Psychopharmacology 132 1997 107 124
9. K. Dains, B. Hitzemann, and R. Hitzemann Genetics, neuroleptic response and the organization of cholinergic neurons in the mouse striatum J Pharmacol Exp Ther 279 1996 1430 1438
10. P. De Boer, G. Damsma, Q. Schram, J.C. Stoof, J. Zaagsma, and B.H. Westerink The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval Naunyn Schmiedebergs Arch Pharmacol 345 1992 144 152
11. S.A. Eagger, R. Levy, and B.J. Sahakian Tacrine in Alzheimer's disease Lancet 338 1991 50 51
12. 2C-induced oral dyskinesia Neuroscience 72 1996 117 128
13. G.L. Ellman, D. Courteny, V. Andres, and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
14. J.C.R. Fernando, B.H. Hoskins, and I.K. Ho A striatal serotonergic involvement in the behavioral effects of anticholinesterase organophosphates Eur J Pharmacol 98 1984 129 132
15. M. Finn, A. Jassen, P. Baskin, and J.D. Salamone Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions Pharmacol Biochem Behav 57 1997 243 249
16. S.E. Freeman, and R.M. Dawson Tacrine: a pharmacological review Prog Neurobiol 36 1991 257 277
17. G.E. Gibson, and T. Manger Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine Biochem Pharmacol 37 1988 4191 4196
18. M. Hallak, and E. Giacobini Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain Neuropharmacology 28 1989 199 206
19. J.A. Harder, and M.E. Kelly The effect of several putative cognition enhancers on a water maze acquisition deficit produced by pCPA + scopolamine combination treatment Pharmacol Biochem Behav 56 1997 657 661
20. C.J. Hunker, and J.H. Abbs Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue, and index finger Move Disord 5 1990 71 77
21. A.J. Hunter, T.K. Murray, J.A. Jones, A.J. Cross, and A.R. Green The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro Br J Pharmacol 98 1989 79 86
22. G.A. Jicha, and J.D. Salamone Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms J Neurosci 11 1991 3822 3829
23. D.R. Liston, J.A. Nielsen, A. Villalobos, D. Chapin, S.B. Jones, and S.T. Hubbard Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease Eur J Pharmacol 486 2004 9 17
24. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
25. A.J. Mayorga, D.L. Carriero, M.S. Cousins, G. Gianutsos, and J.D. Salamone Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects Pharmacol Biochem Behav 56 1997 273 279
26. H. Mehta, B. Thomas, and K.P. Mohanakumar Effects of p- chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats Neurosci Lett 299 2001 105 108
27. H. Mehta, K.S. Saravanan, and K.P. Mohanakumar Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice Behav Brain Res 145 2003 31 36
28. N. Mitra, K.P. Mohanakumar, and D.K. Ganguly Dissociation of serotonergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in mice Brain Res Bull 28 1992 355 364
29. K.P. Mohanakumar, and D.K. Ganguly Tremorogenesis by LON-954 [N-carbamoyl-2-(2,6-dichlorophenyl) acetamidine hydrochloride]: evidence for the involvement of 5-hydroxytryptamine Brain Res Bull 22 1989 191 195
30. K.P. Mohanakumar, N. Mitra, and D.K. Ganguly Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotonergic involvement Neurosci Lett 120 1990 91 93
31. J.A. Nielsen, E.E. Mena, I.H. Williams, M.R. Nocerini, and D. Liston Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes Eur J Pharmacol 173 1989 53 64
32. I. Nordgren, B. Karlen, and M. Kimland Metrifonate and tacrine: a comparative study on their effect on acetylcholine dynamics in mouse brain Pharmacol Toxicol 71 1992 236 240
33. B.R. Ott, and M.C. Lannon Exacerbation of parkinsonism by tacrine Clin Neuropharmacol 15 1992 322 325
34. P.E. Potter, S. Nitta, I. Chaudhry, I. Lalezari, P. Goldiner, and F.F. Foldes Effects of LF-14 THA and physostigmine in rat hippocampus and cerebral cortex Neurochem Int 14 1989 433 438
35. K.S.J. Rao, and G.W. Rao Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity an in vivo kinetic study Mol Cell Biochem 137 1994 57 60
36. P. Riekkinen Jr., and M. Riekkinen Effects of tetrahydroaminoacridine and nicotine in nucleus basalis and serotonin-lesioned rats Eur J Pharmacol 279 1995 65 73
37. M. Riekkinen, L. Aroviita, M. Kivipelto, K. Taskila, and P. Riekkinen Jr. Depletion of serotonin, dopamine and noradrenaline in aged rats decreases the therapeutic effect of nicotine, but not of tetrahydroaminoacridine Eur J Pharmacol 308 1996 243 250
38. T.N. Robinson, R.J. De Souza, A.J. Cross, and A.R. Green The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms Br J Pharmacol 98 1989 1127 1136
39. J. Salamone, B. Carlson, S. Behrstock, and A. Tobin Engineered GABA-releasing cells transplanted into SNr suppress cholinomimetic-induced oral tremor in an animal model of parkinsonism Behav Pharmacol 12 2001 88
40. R. Sarkar, K.P. Mohanakumar, and M. Chowdhury Effects of an organophosphate pesticide, quinalphos, on the hypothalamo-pituitary-gonadal axis in adult male rats J Reprod Fert 118 2000 29 38
41. S. Sarkar, B. Thomas, D. Muralikrishnan, and K.P. Mohanakumar Effects of serotoninergic drugs on tremor induced by physostigmine in rats Behav Brain Res 109 2000 187 193
42. T.M. Shih Time course of the effects of soman poisoning on acetylcholine and choline levels in six discrete areas of the rat brain Psychopharmacology 78 1982 170 175
43. W.K. Summers, K.H. Tachiki, and A. Kling Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies Eur Neurol 29 1989 28 32
44. Y. Tani, K. Saito, A. Tsuneyoshi, M. Imoto, and T. Ono Nicotinioc acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice Psychopharmacology 129 1997 225 232
45. J.T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn, and J.D. Salamone Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function Psychopharmacology 132 1997 74 81
46. C.H. Vanderwolf Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotinergic blockade in the rat Behav Brain Res 23 1987 43 57
47. G. Wang, and S.C. Fowler Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine Psychopharmacology 158 2001 273 280
48. J.M. Witkin, R. Alvarado-Garcia, M.A. Lee, and K.M. Witkin Nonmuscarinic neurotoxicity of oxotremorine J Pharmacol Exp Ther 241 1987 34 41
49. P. Zatta, V. Nicosia, and P. Zambenedetti Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium(III) or tacrine Neurochem Int 32 1998 273 279